Also trades as: 4578.T (JPX) · $vol 93M · OTSKY (OTC) · $vol 2M

$73.16

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 47 · $38.4B mcap · 403M float · 0.0000% daily turnover · Short 87% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$2.47T +6.1% ▲

5Y CAGR: +11.7%

Gross Profit

$1.77T +6.1% ▲

5Y CAGR: +12.5%

Operating Income

$412.8B +27.6% ▲

5Y CAGR: +15.8%

Net Income

$363.5B +5.9% ▲

5Y CAGR: +19.7%

EPS (Diluted)

$685.44 +8.2% ▲

5Y CAGR: +20.3%

EBITDA

$529.1B +16.9% ▲

5Y CAGR: +12.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.50T	$1.74T	$2.02T	$2.33T	$2.47T
YoY Growth	+5.3%	+16.0%	+16.1%	+15.4%	+6.1%
Cost of Revenue	$495.0B	$569.5B	$611.2B	$660.4B	$699.7B
Gross Profit	$1.00T	$1.17T	$1.41T	$1.67T	$1.77T
Gross Margin	67.0%	67.2%	69.7%	71.7%	71.7%
R&D Expenses	$232.3B	$275.2B	$307.8B	$314.2B	$353.1B
SG&A Expenses	$622.3B	$724.1B	$807.4B	$958.3B	$1.01T
Operating Expenses	$850.8B	$1.02T	$1.27T	$1.35T	$1.36T
Operating Income	$154.5B	$150.3B	$139.6B	$323.6B	$412.8B
Operating Margin	10.3%	8.6%	6.9%	13.9%	16.7%
Interest Expense	$4.8B	$6.1B	$6.5B	$8.8B	$27.1B
Income Before Tax	$163.6B	$173.0B	$142.7B	$335.9B	$468.4B
Tax Expense	$34.4B	$35.5B	$17.2B	-$11.4B	$101.9B
Net Income	$125.5B	$133.9B	$121.6B	$343.1B	$363.5B
Net Margin	8.4%	7.7%	6.0%	14.7%	14.7%
EPS (Diluted)	$231.15	$246.79	$224.10	$633.77	$685.44
EBITDA	$231.4B	$279.8B	$247.0B	$452.6B	$529.1B
Shares Outstanding	542M	543M	543M	541M	530M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$621.1B	$599.8B	$582.8B	$597.9B	$647.1B	$650.7B	$634.3B	$697.0B
Cost of Revenue	$166.5B	$177.7B	$156.6B	$168.8B	$183.5B	$192.9B	$175.2B	$190.4B
Gross Profit	$454.6B	$422.1B	$426.2B	$429.1B	$463.6B	$457.8B	$459.1B	$506.5B
Gross Margin	73.2%	70.4%	73.1%	71.8%	71.6%	70.4%	72.4%	72.7%
R&D Expenses	$24.3B	$91.2B	$78.4B	$84.5B	$87.0B	$104.3B	$82.6B	$89.4B
SG&A Expenses	$239.5B	$265.1B	$231.3B	$240.7B	$257.9B	$278.5B	$261.1B	$272.5B
Operating Expenses	$319.9B	$286.3B	$301.8B	$333.1B	$344.8B	$382.8B	$343.7B	$361.9B
Operating Income	$134.8B	$135.8B	$124.4B	$96.0B	$118.7B	$75.0B	$115.4B	$144.7B
Operating Margin	21.7%	22.6%	21.3%	16.1%	18.3%	11.5%	18.2%	20.8%
Interest Expense	$20.9B	$0	$11.1B	$4.7B	$1.4B	$2.2B	$2.1B	$2.7B
Income Before Tax	$113.8B	$79.8B	$113.4B	$113.0B	$168.8B	$75.3B	$131.0B	$154.1B
Tax Expense	$29.5B	$72.5B	$27.4B	$23.1B	$41.5B	$10.5B	$31.1B	$35.7B
Net Income	$83.9B	$151.4B	$85.0B	$88.5B	$125.9B	$65.6B	$99.0B	$116.4B
Net Margin	13.5%	25.3%	14.6%	14.8%	19.5%	10.1%	15.6%	16.7%
EPS (Diluted)	$154.77	$281.41	$158.57	$167.62	$239.00	$123.91	$186.94	$221.19
EBITDA	$168.2B	$89.6B	$145.2B	$133.8B	$188.7B	$107.5B	$145.9B	$175.5B
Shares Outstanding	542M	538M	536M	528M	528M	527M	528M	526M

OTSKF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet